Goldman Sachs

Goldman Sachs’s Aspire Biopharma ASBP Stock Holding History

Goldman Sachs’s Portfolio ASBP Stock Details ASBP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$5.03K	Buy
2023 Q2	–	Sell
2023 Q1	$4.75M	Hold
2022 Q4	$4.67M	Hold
2022 Q3	$4.59M	Buy